首页 | 本学科首页   官方微博 | 高级检索  
检索        

曲美他嗪对心肌保护的研究进展
引用本文:赵志宏,何并文.曲美他嗪对心肌保护的研究进展[J].医学综述,2010,16(7).
作者姓名:赵志宏  何并文
作者单位:广西医科大学附属肿瘤医院麻醉科,南宁,530021
基金项目:广西留学回国人员基金 
摘    要:曲美他嗪作为一种新型的影响心肌代谢类药物,通过其特有的机制使能量代谢从脂肪酸氧化转移到葡萄糖氧化,增加了葡萄糖利用率,提高了ATP生成效率,起到能量优化的作用,从而减少心肌损伤达到心肌保护的作用。目前,曲美他嗪已应用于缺血性心肌病、心绞痛、心力衰竭、缺血/再灌注损伤及冠状动脉旁路移植术、经皮冠状动脉介入的治疗,均有较好的疗效,故具有良好的临床实用价值和应用前景。

关 键 词:曲美他嗪  能量代谢  心肌保护

Progress of Trimetazidine in Myocardial Preservation
ZHAO Zhi-hong,HE Bing-wen..Progress of Trimetazidine in Myocardial Preservation[J].Medical Recapitulate,2010,16(7).
Authors:ZHAO Zhi-hong  HE Bing-wen
Institution:ZHAO Zhi-hong,HE Bing-wen.(Department of Anesthesiology,the Affiliated Cancer Hospital of Guangxi Medical University,Nanning 530021,China)
Abstract:As a new agent acting on myocardial metabolism,trimatazidine protects myocardia against injuries by shifting myocardial energy metabolism from the oxidation of fatty acids towards glucose oxidation to raise the availability of glucose and improve the efficiency of ATP production,leading to the energy optimization.At present,trimetazidine is therapeutically effective in many diseases,including ischemic cardiomyopathy,angina,heart failure,ischemic reperfusion injury,coronary artery bypass graft and percutaneo...
Keywords:Trimetazidine  Energy metabolism  Myocardial preservation  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号